All Work Published on Sciences (Social, Health, Biological, Physical)
Social media platforms are too often understood as monoliths with clear priorities. Instead, we analyze them as complex organizations torn between starkly different justifications of their missions. Focusing on the case of Meta, we inductively analyze the company’s public materials and identify three evaluative logics that shape the platform’s decisions: an engagement logic, a public debate logic, and a wellbeing logic. There are clear trade-offs between these logics, which often result in internal conflicts between teams and departments in charge of these different priorities. We examine recent examples showing how Meta rotates between logics in its decision-making, though the goal of engagement dominates in internal negotiations. We outline how this framework can be applied to other social media platforms such as TikTok, Reddit, and X. We discuss the ramifications of our findings for the study of online harms, exclusion, and extraction.
Social media platforms are too often understood as monoliths with clear priorities. Instead, we analyze them as complex organizations torn between starkly different justifications of their missions. Focusing on the case of Meta, we inductively analyze the company’s public materials and identify three evaluative logics that shape the platform’s decisions: an engagement logic, a public debate logic, and a wellbeing logic. There are clear trade-offs between these logics, which often result in internal conflicts between teams and departments in charge of these different priorities. We examine recent examples showing how Meta rotates between logics in its decision-making, though the goal of engagement dominates in internal negotiations. We outline how this framework can be applied to other social media platforms such as TikTok, Reddit, and X. We discuss the ramifications of our findings for the study of online harms, exclusion, and extraction.
Stanford computer scientist James Zou is exploring how AI can accelerate scientific research and peer review. His finding: AI excels at spotting gaps, but judgment calls still need humans.
Stanford computer scientist James Zou is exploring how AI can accelerate scientific research and peer review. His finding: AI excels at spotting gaps, but judgment calls still need humans.
Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c < 7%), early technology use (continuous glucose monitoring starts <1 month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study 1). Primary outcome was HbA1c change from 4 to 12 months after diagnosis; the secondary outcome was achieving the HbA1c targets. The 4T Study 1 cohort (36.8% Hispanic and 35.3% publicly insured) had a mean HbA1c of 6.58%, 64% with HbA1c < 7% and mean time in the range (70-180 mg dl-1) of 68% at 1 year after diagnosis. Clinical implementation of the 4T Study 1 met the prespecified primary outcome and improved glycemia without unexpected serious adverse events. The strategies in the 4T Study 1 can be used to implement systematic and equitable care for individuals with T1D and translate to care for other chronic diseases.
Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c < 7%), early technology use (continuous glucose monitoring starts <1 month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study 1). Primary outcome was HbA1c change from 4 to 12 months after diagnosis; the secondary outcome was achieving the HbA1c targets. The 4T Study 1 cohort (36.8% Hispanic and 35.3% publicly insured) had a mean HbA1c of 6.58%, 64% with HbA1c < 7% and mean time in the range (70-180 mg dl-1) of 68% at 1 year after diagnosis. Clinical implementation of the 4T Study 1 met the prespecified primary outcome and improved glycemia without unexpected serious adverse events. The strategies in the 4T Study 1 can be used to implement systematic and equitable care for individuals with T1D and translate to care for other chronic diseases.
Stanford scientists in Senegal hunting for schistosomiasis—a parasitic disease infecting 200+ million people worldwide—used AI to transform local field work into satellite-powered disease mapping.
Stanford scientists in Senegal hunting for schistosomiasis—a parasitic disease infecting 200+ million people worldwide—used AI to transform local field work into satellite-powered disease mapping.
